STAT signaling in ischemic heart: a role of STAT5A in ischemic preconditioning.

We recently demonstrated that ischemic preconditioning (PC) induced by cyclic episodes of short duration of ischemia and reperfusion potentiates a signal transduction cascade involving Janus kinase (JAK) 2 and signal transducer and activator of transcription 3 (STAT3). A rapid activation of JAK and several STATs, including STAT3, STAT5A, and STAT6 also occurred during myocardial ischemia and reperfusion. This study sought to examine whether STAT5A and STAT6 were also involved in PC. Two different animal models were used: isolated perfused working rat hearts and STAT5A and STAT6 knockout mouse hearts. The results of our study indicated phosphorylation of STAT 5A and STAT6 in the preconditioned myocardium. Tyrphostin AG490, a JAK2 inhibitor, or 4-amino-5-(4-methylphenyl)-7-(t-butyl)-pyrazolo-3,4-d-pyrimidine (PPI), a Src kinase blocker, blocked STAT5A phosphorylation, whereas STAT6 phosphorylation was blocked only with tyrphostin. As expected, significant cardioprotection was achieved in the preconditioned heart as evidenced by reduced myocardial infarct size and decreased number of apoptotic cardiomyocytes. PC-mediated cardioprotection was partially abolished when hearts were pretreated with tyrphostin, PPI, or LY-294002, a phosphatidylinositol (PI)-3 kinase inhibitor. Studies with STAT5A and STAT6 knockout mouse hearts revealed that STAT6 knockout mouse hearts, and not STAT5A knockout mouse hearts, were resistant to myocardial ischemia-reperfusion injury. The hearts from STAT5A knockout mice could not be preconditioned, whereas those from STAT6 knockout mice were easily preconditioned. The results of the present study demonstrate that STAT5A, and not STAT6, plays a role in ischemic PC. For the first time, the results also indicated a role of Src kinase pathway in STAT5A PC and PI-3 kinase-Akt pathways appear to be the downstream regulator for STAT5A-STAT6 signaling pathway.

[1]  Jing-Jy Cheng,et al.  Cyclic Strain Activates Redox-sensitive Proline-rich Tyrosine Kinase 2 (PYK2) in Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[2]  G. Booz,et al.  Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure. , 2002, Journal of molecular and cellular cardiology.

[3]  G. Rao,et al.  5(S)-Hydroxyeicosatetraenoic Acid Stimulates DNA Synthesis in Human Microvascular Endothelial Cells via Activation of Jak/STAT and Phosphatidylinositol 3-Kinase/Akt Signaling, Leading to Induction of Expression of Basic Fibroblast Growth Factor 2* , 2002, The Journal of Biological Chemistry.

[4]  D. Ribatti,et al.  In vivo activation of JAK2/STAT‐3 pathway during angiogenesis induced by GM‐CSF , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  L. Yu-Lee.  Prolactin modulation of immune and inflammatory responses. , 2002, Recent progress in hormone research.

[6]  N. Maulik,et al.  Role of STAT3 in ischemic preconditioning. , 2001, Journal of molecular and cellular cardiology.

[7]  N. Maulik,et al.  Src tyrosine kinase is the trigger but not the mediator of ischemic preconditioning. , 2001, American journal of physiology. Heart and circulatory physiology.

[8]  R. Bolli,et al.  An essential role of the JAK-STAT pathway in ischemic preconditioning , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[9]  N. Maulik,et al.  JAK/STAT Signaling Is Associated With Cardiac Dysfunction During Ischemia and Reperfusion , 2001, Circulation.

[10]  J. Alam,et al.  Hmox-1 Constitutes an Adaptive Response to Effect Antioxidant Cardioprotection: A Study With Transgenic Mice Heterozygous for Targeted Disruption of the Heme Oxygenase-1 Gene , 2001, Circulation.

[11]  D. Das,et al.  Transgene overexpression of αB crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion , 2001 .

[12]  S. Beppu,et al.  Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats. , 2001, Journal of molecular and cellular cardiology.

[13]  N. Maulik,et al.  Regulation of cardiomyocyte apoptosis by redox‐sensitive transcription factors , 2000, FEBS letters.

[14]  N. Maulik,et al.  Myocardial Protection by Preconditioning of Heart With Losartan, an Angiotensin II Type 1-Receptor Blocker: Implication of Bradykinin-Dependent and Bradykinin-Independent Mechanisms , 2000, Circulation.

[15]  J. Williams,et al.  STAT signalling in cell proliferation and in development. , 2000, Current opinion in genetics & development.

[16]  N. Maulik,et al.  SAPKs regulation of ischemic preconditioning. , 2000, American journal of physiology. Heart and circulatory physiology.

[17]  MasatsuguHori,et al.  Protein Tyrosine Kinase Is Not Involved in the Infarct Size–Limiting Effect of Ischemic Preconditioning in Canine Hearts , 2000 .

[18]  W. Chen,et al.  Ischemic Preconditioning Activates Phosphatidylinositol-3-Kinase Upstream of Protein Kinase C , 2000, Circulation research.

[19]  K. Shimamoto,et al.  Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation. , 2000, Circulation.

[20]  N. Maulik,et al.  Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. , 1999, Circulation.

[21]  P. Ping,et al.  Demonstration of selective protein kinase C-dependent activation of Src and Lck tyrosine kinases during ischemic preconditioning in conscious rabbits. , 1999, Circulation research.

[22]  P. Kowey,et al.  Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery. , 1999, Circulation.

[23]  P. Parker,et al.  Src promotes PKCδ degradation , 1999 .

[24]  P. Parker,et al.  Src Promotes PKCd Degradation , 1999 .

[25]  P. Besmer,et al.  Kit signaling through PI 3‐kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation , 1998, The EMBO journal.

[26]  J. Downward.  Mechanisms and consequences of activation of protein kinase B/Akt. , 1998, Current opinion in cell biology.

[27]  S. R. Datta,et al.  Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.

[28]  S. Akira,et al.  Essential role of Stat6 in IL-4 signalling , 1996, Nature.

[29]  S. McKnight,et al.  An interleukin-4-induced transcription factor: IL-4 Stat. , 1994, Science.